New Program to Address Impaired Driving from Alcohol, Cannabis and Prescription Drugs (external site)
A new program is addressing impaired driving from alcohol, cannabis and prescription drugs.
UC San Diego Health, the region’s only academic medical center, delivers world-class care and translates groundbreaking research into promising new treatments for patients.
A new program is addressing impaired driving from alcohol, cannabis and prescription drugs.
Two renowned research centers at University of California San Diego are joining forces to take a deeper look at how components of human milk and the microbiome can change the course of therapeutics for infant and adult diseases.
Researchers at UC San Diego School of Medicine, with colleagues, describe a new method for delivering neural precursor cells to spinal cord injuries in rats, reducing the risk of further injury and boosting the propagation of potentially reparative cells.
UC San Diego Health is conducting the first known randomized, double-blind, placebo-controlled clinical trial looking at cannabis as a potentially effective treatment for acute migraines.
Researchers at UC San Diego School of Medicine and Rady Children’s Institute for Genomic Medicine have been awarded a five-year, $8.3 million grant from the National Institutes of Health to investigate the causes of spina bifida, the most common structural defect of the central nervous system.
The Psychedelics and Health Research Initiative at UC San Diego has received a $1.3 million grant from the Steven & Alexandra Cohen Foundation to fund a clinical trial investigating the therapeutic potential of psilocybin in treating phantom limb pain.
San Diego Magazine, October 29
Imperial Valley Weekly, November 2
FOX 5, November 5
Escondido Times-Advocate, November 5
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
You have been successfully subscribed to the UC San Diego Today Newsletter.